CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Nortriptylinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000377
NCT00000377N/ACompleted

Maintenance Therapies in Late-Life Depression

University of Pittsburgh·interventional·Posted Nov 3, 1999·Updated Jun 21, 2013

In Brief

A clinical study evaluating Nortriptyline for Depression. Completed.

Detailed Summary

The purpose of this study is to compare the effectiveness of two doses of nortriptyline in elderly patients whose depression returned after stopping treatment. Nortriptyline is an antidepressant. This study enrolls patients who were treated for depression in an earlier research study and whose depression has returned since stopping treatment. Patients are treated for 4 months to bring the depression under control. Patients are then assigned randomly (like tossing a coin) to receive either the full dose of nortriptyline or half the usual dose of nortriptyline. Patients continue taking nortriptyline for 2 years or until a major depression returns. Throughout the study, patients are monitored for symptoms of depression and other side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
Countries--

Timeline

N/ACompletedFinished
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 3, 1999
Enrollment StartMar 1, 1989
Primary CompletionApr 1, 2000
TodayJul 2, 2026
Enrollment to primary: 11.1 yearsPosted 26.7 years ago

Interventions

Nortriptylinedrug